방법 비교

	EQ-5D	PROMIS	SF-36 건강 조사
분야	건강 측정	건강 측정	건강 측정
계열	Process / pipeline	Process / pipeline	Process / pipeline
기원 연도	1990	2010	1992
창시자	EuroQol Group	National Institutes of Health (NIH) and National Center for Health Statistics (NCHS)	John E. Ware Jr. and Cathy D. Sherbourne
유형	Generic preference-based health utility measure	Computer-adaptive testing and fixed-length patient-reported outcome measures	Self-report health status instrument
원전	Rabin, R., & de Charro, F. (2001). EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.	Cella, D., Yount, S., Rothrock, N., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Medical Care, 45(Suppl 1), S3–S11.	Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.
별칭	EQ-5D-3L, EQ-5D-5L, EuroQol	PROMIS measures, NIH PROMIS, Computer Adaptive Testing PROMIS	SF-36 Questionnaire, Medical Outcomes Study SF-36
관련	5	5	5
요약	The EQ-5D is a standardized, preference-based health utility measure developed by the EuroQol Group in 1990. It combines a descriptive health profile (five dimensions, three or five response levels) with a visual analog scale to quantify overall health status. The instrument has become essential for health economics, clinical trials, and cost-effectiveness analysis worldwide.	The Patient-Reported Outcomes Measurement Information System (PROMIS) is a comprehensive, flexible system of patient-reported outcome measures developed by the National Institutes of Health. Launched in 2010, PROMIS measures health across multiple domains using both fixed-item forms and computer-adaptive testing (CAT). It has become the gold standard for outcomes measurement in clinical trials and health systems research.	The SF-36 is a generic, self-administered 36-item questionnaire measuring eight dimensions of health status. Developed by Ware and Sherbourne in 1992, it has become the most widely used health survey in clinical trials, outcomes research, and population health monitoring. It assesses perceived health across physical and mental domains relevant to the general adult population.